Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Amminger

Showing results (11-20 of 191) with videos related to

Pageof 20
Sort By:
Schizophrenia Research|October 23, 2018
Current versus recently resolved attenuated psychotic symptoms: Same level of risk for transition to psychosis?Simon M Rice, Patrick D McGorry, G Paul Amminger, et al.
European Child & Adolescent Psychiatry|June 7, 2018
Natural killer cell function in adolescent and adult schizophrenic patientsFranz Resch, G Paul Amminger, Harald Aschauer, et al.
Brain and Behavior|October 27, 2016
Characterizing neurocognitive impairment in young people with major depression: state, trait, or scar?Kelly Allott, Caroline A Fisher, Gunther Paul Amminger, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2020
Testing the Effects of Dietary Seafood Consumption on Depressive SymptomsMaximus Berger, G Paul Amminger, Robyn McDermott, et al.
Early Intervention in Psychiatry|August 24, 2013
Metabolic changes in first-episode early-onset schizophrenia with second-generation antipsychoticsBrian O'Donoghue, Miriam R Schäfer, Jana Becker, et al.
Early Intervention in Psychiatry|January 26, 2013
Is basic self-disturbance in ultra-high risk for psychosis ('prodromal') patients associated with borderline personality pathology?Barnaby Nelson, Andrew Thompson, Andrew M Chanen, et al.
Neuropsychiatrie : Klinik, Diagnostik, Therapie Und Rehabilitation : Organ Der Gesellschaft Osterreichischer Nervenarzte Und Psychiater|June 9, 2007
[Early detection of psychotic disorders]Miriam R Schäfer, Claudia M Klier, Konstantinos Papageorgiou, et al.
Neuroscience and Biobehavioral Reviews|May 28, 2016
Cortisol awakening response in patients with psychosis: Systematic review and meta-analysisMaximus Berger, Ann Katrin Kraeuter, Daria Romanik, et al.
Early Intervention in Psychiatry|September 13, 2015
Changes in triglyceride levels in ultra-high risk for psychosis individuals treated with omega-3 fatty acidsNilufar Mossaheb, Konstantinos Papageorgiou, Miriam R Schäfer, et al.
Nature Communications|August 12, 2015
Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 studyG Paul Amminger, Miriam R Schäfer, Monika Schlögelhofer, et al.
Pageof 20

Showing results (11-20 of 191) with videos related to

Sort By:
Pageof 20
Schizophrenia Research|October 23, 2018
Current versus recently resolved attenuated psychotic symptoms: Same level of risk for transition to psychosis?Simon M Rice, Patrick D McGorry, G Paul Amminger, et al.
European Child & Adolescent Psychiatry|June 7, 2018
Natural killer cell function in adolescent and adult schizophrenic patientsFranz Resch, G Paul Amminger, Harald Aschauer, et al.
Brain and Behavior|October 27, 2016
Characterizing neurocognitive impairment in young people with major depression: state, trait, or scar?Kelly Allott, Caroline A Fisher, Gunther Paul Amminger, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2020
Testing the Effects of Dietary Seafood Consumption on Depressive SymptomsMaximus Berger, G Paul Amminger, Robyn McDermott, et al.
Early Intervention in Psychiatry|August 24, 2013
Metabolic changes in first-episode early-onset schizophrenia with second-generation antipsychoticsBrian O'Donoghue, Miriam R Schäfer, Jana Becker, et al.
Early Intervention in Psychiatry|January 26, 2013
Is basic self-disturbance in ultra-high risk for psychosis ('prodromal') patients associated with borderline personality pathology?Barnaby Nelson, Andrew Thompson, Andrew M Chanen, et al.
Neuropsychiatrie : Klinik, Diagnostik, Therapie Und Rehabilitation : Organ Der Gesellschaft Osterreichischer Nervenarzte Und Psychiater|June 9, 2007
[Early detection of psychotic disorders]Miriam R Schäfer, Claudia M Klier, Konstantinos Papageorgiou, et al.
Neuroscience and Biobehavioral Reviews|May 28, 2016
Cortisol awakening response in patients with psychosis: Systematic review and meta-analysisMaximus Berger, Ann Katrin Kraeuter, Daria Romanik, et al.
Early Intervention in Psychiatry|September 13, 2015
Changes in triglyceride levels in ultra-high risk for psychosis individuals treated with omega-3 fatty acidsNilufar Mossaheb, Konstantinos Papageorgiou, Miriam R Schäfer, et al.
Nature Communications|August 12, 2015
Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 studyG Paul Amminger, Miriam R Schäfer, Monika Schlögelhofer, et al.
Pageof 20